会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 레몬버베나 유래 액티오사이드 함유 추출물 및 이를 포함하는 기능성 화장료 조성물
    • 提取物含有来自LIPPIA CITRIODORA的活性成分和含有它的化妆品组合物
    • KR1020130089384A
    • 2013-08-12
    • KR1020120010709
    • 2012-02-02
    • (주)모아캠
    • 주철규이근하박청조영롱이재성김고운주일우정용철
    • A61K36/85A61K8/97A61P17/00A61Q19/00
    • PURPOSE: A cosmetic composition is provided to contain a high content of acteoside isolated and purified from Lippia citriodora as an active ingredient, and have effects of antioxidant, whitening, anti-wrinkle, anti-inflammation, antibiotic, improvement of atopy, and UV protection. CONSTITUTION: A manufacturing method of Lippia citiodora extract containing acteoside is comprises: a step of extracting acteoside by adding a solvent to Lippia citriodora, and concentrating; a step of obtaining acteoside fraction by adding more than two kinds of solvents selected from the group comprising of water, ethanol, methanol, butanol, ethyl acetate, ethyl ether, chloroform and hexane to the concentrated extract; a step of removing the organic solvents and manufacturing fraction concentration powder by secondary concentration; a step of removing pigment and chlorophyll using column after dissolving the fraction concentration powder in solvent; a step of recrystalizing the extract, in which the pigment and chlorophyll are removed, by precipitation under the controlled pressure and temperature; and a step of obtaining powder type acteoside by spray drying or freeze drying the precipitated pellet. A functional cosmetic composition comprises Lippia citriodora extract containing the acteoside as an active ingredient. [Reference numerals] (AA) Sample 1 (Sample 5)
    • 目的:提供一种化妆品组合物,其含有从柠檬提取物中分离和纯化的高含量的肌动蛋白作为活性成分,具有抗氧化,美白,抗皱,抗炎,抗生素,改善特应性和抗紫外线的作用 。 构成:含有肌动蛋白的Lippia citiodora提取物的制造方法包括:通过向柠檬提取物提取溶剂并浓缩的步骤; 通过向浓缩提取物中加入选自水,乙醇,甲醇,丁醇,乙酸乙酯,乙醚,氯仿和己烷组成的组中的两种以上的溶剂来获得肌苷类成分的步骤; 通过二次浓缩除去有机溶剂并制备级分浓度粉末的步骤; 在将级分浓缩粉末溶解在溶剂中后,使用柱子除去颜料和叶绿素的步骤; 在控制的压力和温度下通过沉淀来除去其中除去颜料和叶绿素的提取物的步骤; 以及通过喷雾干燥或冷冻干燥沉淀的颗粒来获得粉末型acteoside的步骤。 功能性化妆品组合物包含含有作为活性成分的所述acteoside的柠檬提取物(Lippia citriodora)提取物。 (标号)(AA)样品1(样品5)
    • 3. 发明公开
    • 층꽃풀 추출물 또는 이로부터 분리된 화합물을 함유하는 간독성 질환 예방 및 치료용 조성물
    • 包含来自阴囊炎的提取物的化学保护性药物组合物及其分离的化合物
    • KR1020120119105A
    • 2012-10-30
    • KR1020110036866
    • 2011-04-20
    • 한국과학기술연구원
    • 진창배김형자이용섭정서윤
    • A61K36/85A61P1/16A61P1/00
    • A61K36/53
    • PURPOSE: A composition for preventing and treating hepatotoxicity diseases containing caryopteris incana extracts or a compound separated from the same is provided to enhance protective effectson hepatic cells. CONSTITUTION: A composition for preventing and treating hepatotoxicity diseases contains caryopteris incana extracts or a compound separated from the same. The caryopteris incana extract is obtained by extracting the caryopteris incana with water, C1-C4 alcohol or a mixed solvent thereof. The alcohol is methanol or ethanol. The caryopteris incana fraction is a fractions obtained by dichloromethane(CH2Cl2), ethyl acetate or butanol. The caryopteris incana extracts are compounds represented by chemical formula 1-10. The hepatotoxicity disease is drug caused liver damage, viral liver damage, hepatitis, liver hardening, liver cancer or hepatic coma. A pharmaceutical composition for preventing and treating the hepatotoxicity diseases includes the compound of the chemical formula 1-10 or salt which is pharmaceutically acceptable.
    • 目的:提供一种用于预防和治疗含有鳞翅目植物提取物或与其分离的化合物的肝毒性疾病的组合物,以增强对肝细胞的保护作用。 构成:用于预防和治疗肝毒性疾病的组合物含有鳞翅目刺槐提取物或从其分离的化合物。 通过用水,C 1 -C 4醇或其混合溶剂萃取ary is is,获得ary ana提取物。 醇是甲醇或乙醇。 鳞翅目分数是通过二氯甲烷(CH 2 Cl 2),乙酸乙酯或丁醇得到的级分。 ary ana提取物是化学式1-10表示的化合物。 肝毒性疾病是药物引起肝损害,病毒性肝损伤,肝炎,肝硬化,肝癌或肝昏迷。 用于预防和治疗肝毒性疾病的药物组合物包括化学式1-10的化合物或药学上可接受的盐。
    • 5. 发明公开
    • 간 질환 예방 및 치료와 간 보호 효과를 갖는 만형자추출물 및 그의 제조 방법
    • 提取物用于预防或治疗肝脏疾病和/或其生产和使用方法的提取物
    • KR1020070068135A
    • 2007-06-29
    • KR1020050129901
    • 2005-12-26
    • 일동홀딩스(주)
    • 유정수이영호노동형홍재선
    • A61K36/85A61P1/16A61P39/06
    • An extract of Viticis fructus is provided to have the free radical scavenging capability, be able to lower the AST and ALT values and inhibit the hepatic damage such as infiltration of inflammatory cells and vacuole degeneration of hepatic cells, thereby being used for protecting the liver, and preventing and treating hepatic diseases. The extract of Viticis fructus has prophylactic and therapeutic effect of the hepatic diseases or the hepatic protecting effect and is prepared by extracting Viticis fructus with at least one water-soluble organic solvent selected from the group consisting of methanol, ethanol and acetone to obtain a crude extract, and collecting ingredients, which are soluble in at least one water-insoluble organic solvent selected from the group consisting of chloroform, dichloromethane, ethylacetate, and toluene, from the crude extract.
    • 提供维生素提取物具有自由基清除能力,能够降低AST和ALT值,抑制炎症细胞浸润和肝细胞液泡变性等肝损伤,从而用于保护肝脏, 并预防和治疗肝病。 维生素提取物具有肝脏疾病或肝脏保护作用的预防和治疗作用,并且通过用至少一种选自甲醇,乙醇和丙酮的水溶性有机溶剂提取葡萄果实制备,得到粗品 从粗提取物中提取和收集可溶于至少一种选自氯仿,二氯甲烷,乙酸乙酯和甲苯的水不溶性有机溶剂的成分。
    • 8. 发明公开
    • 건조 추출물들을 생산하는 방법
    • 生产干燥提取物的方法
    • KR1020140054277A
    • 2014-05-08
    • KR1020147007049
    • 2012-08-20
    • 비오노리카 에스에
    • 폽,미햐엘
    • A61K36/70A61K36/85A61K9/20A61K9/48A61P31/12A61P29/00
    • A61K36/85A23L33/105A23V2002/00A61K36/185A61K36/35A61K36/515A61K36/70A61K2236/33A61K2300/00
    • 본 발명은 건조 식물 추출물들을 생산하는 방법 및 이를 포함하는 약학적 조제물들에 관한 것이고, 보다 상세하게는 식물(약물)의 에탄올성/수용성 추출물의 적어도 하나를 포함하는 식물성 약제들(phytopharmaceuticals)로서, 식물들은
      루멕스 아세토사 L. (
      Rumex acetosa L. ),
      루멕스 아세토셀라 L. (
      Rumex acetosella L. ),
      루멕스 오브투시폴리우스 L. (
      Rumex obtusifolius L. ),
      루멕스 파티엔티아
      L. (
      Rumex patientia L. ),

      루멕스 크리스푸스 L. (
      Rumex crispus L. )(이하, 본 명세서에서 총체적인 용어 "
      루미시스 헤르바 (
      Rumicis herba )"라고 언급됨);
      베르베나 오피시날리스 (
      Verbena officinalis );
      삼부쿠스 니그라 (
      Sambucus nigra );
      프리물라 베리스 (
      Primula veris ); 및
      젠티아나 루테아 (
      Gentiana lutea ) 그리고 그들의 혼합물들로 이루어진 그룹으로부터 선택되는, 식물성 약제들에 관한 것이다. 본 발명은 코와 인후 부위 및/또는 부비강들의 염증성 및/또는 감염성 질환들을 치료하는 약제, 및 식품 보충제에, 또한 그들의 용도에도 관한 것이다.
    • 本发明涉及一种用于生产植物干性提取物的方法和含有该植物的药物制剂的方法,更具体地说是植物药物,其含有植物(药物)的至少一种乙醇/水提取物,所述植物选自: 柳梅属 马鞭草 黑曲霉 报春花 和龙胆草及其混合物。 本发明还涉及用于治疗鼻部和喉部区域和/或鼻窦炎症和/​​或感染性疾病的药物及其用途。
    • 9. 发明公开
    • 독활 및 만형자의 혼합 생약 추출물을 유효성분으로함유하는 관절염의 예방 및 치료용 조성물
    • 包含ARALIA CORDATA THUNB和VITEX ROTUNDIFOLIA L.混合提取物的组合物用于预防和治疗ARTHRITIS
    • KR1020080055205A
    • 2008-06-19
    • KR1020060128211
    • 2006-12-14
    • 경희대학교 산학협력단
    • 박동석유명철최도영이재동백용현허정은조용백한창균이해인정기원
    • A61K36/25A61K36/85A61P19/02
    • A composition comprising the mixed extracts of Aralia cordata THUNB and Vitex rotundifolia L. fil is provided to suppress edema and pain, inhibit proteoglycan in articular cartilage cell and activity of MMP-1(matrix metalloproteinase-1) and MMP-3, and induce no cytotoxicity and morphological change, so that the composition is useful for preventing and treating arthritis. A pharmaceutical or health food composition for preventing and treating arthritis comprises 0.1-50 wt.% of the mixed extracts of Aralia cordata THUNB and Vitex rotundifolia L. fil which are prepared by extracting them with water, C1-C4 lower alcohol including methanol or ethanol, or a mixed solvent thereof, wherein the arthritis is degenerative arthritis, rheumatoid arthritis or Lupus arthritis; and the daily dosage of the mixed extracts is 0.01mg/kg-10g/kg, preferably 1 mg/kg-1g/kg.
    • 提供包含Aralia cordata THUNB和Vitex rotundifolia L. fil的混合提取物的组合物,以抑制水肿和疼痛,抑制关节软骨细胞中的蛋白聚糖和MMP-1(基质金属蛋白酶-1)和MMP-3的活性,并诱导无 细胞毒性和形态变化,使得该组合物可用于预防和治疗关节炎。 用于预防和治疗关节炎的药物或保健食品组合物包括通过用水,C1-C4低级醇(包括甲醇或乙醇)提取它们制备的Aralia cordata THUNB和Vitex rotundifolia L. fil的混合提取物的0.1-50重量% 或其混合溶剂,其中所述关节炎是退行性关节炎,类风湿性关节炎或狼疮性关节炎; 混合提取物的日剂量为0.01mg / kg-10g / kg,优选为1mg / kg-1g / kg。
    • 10. 发明公开
    • 유근피 추출물을 포함하는, 갭 결합을 통한 세포간정보전달의 억제 및 항상성의 불균형과 관련된 질환의예방 또는 치료용 조성물
    • 用于预防和治疗与抑制GAP JUNCTIONAL COMMUNICATION和不平衡的家畜疾病相关的疾病的组合物,包含ULMUS MACROCARPA HANCE EXTRACTINTERNAL CELLULAR
    • KR1020040060323A
    • 2004-07-06
    • KR1020020087093
    • 2002-12-30
    • 재단법인서울대학교산학협력재단
    • 이형주이기원김영준이상준강경선
    • A61K36/85A61K129/00
    • PURPOSE: Provided is a composition for preventing and treating disease associated with inhibition of gap junctional internal cellular communication and unbalance of Homeostasis, which composition contains Ulmus macrocarpa HANCE extract and effectively recovers the inhibition of gap junctional internal cellular communication and the unbalance of Homeostasis. It is therefore, used for manufacture of medicaments, processed foods, functional foods, beverages and drinks. CONSTITUTION: A composition for preventing and treating disease associated with inhibition of gap junctional internal cellular communication and unbalance of Homeostasis is characterized by containing, as an active ingredient, an effective amount of Ulmus macrocarpa HANCE extract or its active fraction, and pharmaceutically acceptable carriers. The extract is obtained by extracting Ulmus macrocarpa HANCE with 60% ethanol solution or hot water.
    • 目的:提供一种预防和治疗与间质连接内部细胞交流抑制和稳态不平衡相关疾病的组合物,该组合物含有榆树枸杞提取物,有效恢复间隙连接内部细胞通讯的抑制和稳态的不平衡。 因此,它用于制造药物,加工食品,功能食品,饮料和饮料。 构成:用于预防和治疗与间质连接内细胞连通抑制和稳态不平衡有关的疾病的组合物,其特征在于,含有有效量的榆树枸杞提取物或其活性成分和药学上可接受的载体作为活性成分。 提取物通过用60%乙醇溶液或热水提取榆树胭脂红获得。